Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 3,075 | 56,376 | 16,787 | 2,639 | 3,797 |
| Cost of Goods | 52 | 59 | 798 | 38 | 22 |
| Gross Profit | 3,023 | 56,317 | 15,989 | 2,601 | 3,775 |
| Operating Expenses | 161,705 | 136,457 | 155,803 | 189,371 | 218,983 |
| Operating Income | -158,630 | -80,081 | -139,016 | -186,732 | -215,186 |
| Other Income | 18,740 | 15,081 | 18,259 | 20,106 | 17,563 |
| Pre-tax Income | -139,890 | -65,000 | -120,757 | -166,626 | -197,623 |
| Income Tax | -1,512 | 276 | -4,784 | -3,213 | -2,848 |
| Net Income Continuous | -138,378 | -65,276 | -115,973 | -163,413 | -194,775 |
| Net Income | $-138,378 | $-65,276 | $-115,973 | $-163,413 | $-194,775 |
| EPS Basic Total Ops | -1.02 | -0.48 | -0.86 | -1.22 | -1.45 |
| EPS Basic Continuous Ops | -1.02 | -0.48 | -0.86 | -1.22 | -1.45 |
| EPS Diluted Total Ops | -1.02 | -0.48 | -0.86 | -1.22 | -1.45 |
| EPS Diluted Continuous Ops | -1.02 | -0.48 | -0.86 | -1.22 | -1.45 |
| EPS Diluted Before Non-Recurring Items | -1.02 | -0.48 | -0.86 | N/A | N/A |
| EBITDA(a) | $-151,733 | $-75,326 | $-133,186 | $-179,837 | $-213,439 |